ES2199098T1 - Metodo para la extraccion y uso de peptidos que son activos como antibioticos para tratar enfermedades infecciosas. - Google Patents

Metodo para la extraccion y uso de peptidos que son activos como antibioticos para tratar enfermedades infecciosas.

Info

Publication number
ES2199098T1
ES2199098T1 ES01960288T ES01960288T ES2199098T1 ES 2199098 T1 ES2199098 T1 ES 2199098T1 ES 01960288 T ES01960288 T ES 01960288T ES 01960288 T ES01960288 T ES 01960288T ES 2199098 T1 ES2199098 T1 ES 2199098T1
Authority
ES
Spain
Prior art keywords
peptides
antibiotics
extraction
active
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES01960288T
Other languages
English (en)
Other versions
ES2199098T3 (es
Inventor
Cornelia Liepke
Susann Arndt
Wolf-Georg Forssmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPF Pharmaceuticals GmbH
Original Assignee
IPF Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPF Pharmaceuticals GmbH filed Critical IPF Pharmaceuticals GmbH
Publication of ES2199098T1 publication Critical patent/ES2199098T1/es
Application granted granted Critical
Publication of ES2199098T3 publication Critical patent/ES2199098T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/762—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Péptido con la secuencia de aminoácidos NH2-YIVYKIRSADKRSKALK-COOH (SEC. ID Nº 5) así como - los derivados amidados, acetilados, sulfatados, fosforilados, glicosilados, oxidados, - péptidos que se obtuvieron por el intercambio conservador de aminoácidos, - péptidos que se obtuvieron mediante la supresión de no más del 10% de los aminoácidos del péptido de SEC. ID Nº 5, y - fragmentos del péptido de SEC. ID Nº 5, con la condición de que los derivados, fragmentos y péptidos presenten un efecto antimicrobiano de al menos el 50% del efecto antimicrobiano del péptido de SEC. ID Nº 5.
ES01960288T 2000-06-08 2001-06-08 Procedimiento para la obtencion y uso de peptidos de efecto antibiotico para el tratamiento de enfermedades infecciosas. Expired - Lifetime ES2199098T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10027992 2000-06-08
DE10027992 2000-06-08

Publications (2)

Publication Number Publication Date
ES2199098T1 true ES2199098T1 (es) 2004-02-16
ES2199098T3 ES2199098T3 (es) 2006-10-01

Family

ID=7644875

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01960288T Expired - Lifetime ES2199098T3 (es) 2000-06-08 2001-06-08 Procedimiento para la obtencion y uso de peptidos de efecto antibiotico para el tratamiento de enfermedades infecciosas.

Country Status (6)

Country Link
EP (2) EP1313763B1 (es)
AT (1) ATE319740T1 (es)
AU (1) AU2001281821A1 (es)
DE (1) DE50109168D1 (es)
ES (1) ES2199098T3 (es)
WO (1) WO2001094386A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449545B2 (en) 2001-12-07 2008-11-11 Ipf Pharmaceuticals Gmbh Antimicrobial bolisin peptides
DE10327518A1 (de) * 2003-06-17 2005-01-13 Klett-Loch, Lore Maria Synthetische Peptidkombinationen und Verfahren zu deren Herstellung
DK1778271T3 (da) * 2004-08-18 2009-02-16 Ipf Pharmaceuticals Gmbh Peptid til behandling af herpesvirusinfektioner
EP2789343A1 (en) * 2013-04-11 2014-10-15 Clinique La Prairie Novel hemoglobin-derived peptide based pharmaceutical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031706A1 (en) * 1997-01-15 1998-07-23 Johns Hopkins University METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP)
JP2001527412A (ja) * 1997-05-14 2001-12-25 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 抗菌ペプチド
CA2309554A1 (en) * 1997-10-08 1999-04-15 Theragem, Inc. Mammalian-derived peptides for the treatment of microbial infection

Also Published As

Publication number Publication date
AU2001281821A1 (en) 2001-12-17
WO2001094386A2 (de) 2001-12-13
EP1313763A2 (de) 2003-05-28
EP1481988A3 (de) 2005-02-23
ATE319740T1 (de) 2006-03-15
EP1313763B1 (de) 2006-03-08
WO2001094386A3 (de) 2003-03-20
DE50109168D1 (de) 2006-05-04
ES2199098T3 (es) 2006-10-01
EP1481988A2 (de) 2004-12-01

Similar Documents

Publication Publication Date Title
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
AR002832A1 (es) Haloperoxidasas obtenidas de curvularia verruculosa, acidos nucleicos que las codifican, vector recombinante, celula huesped recombinante, metodos paraproducir dichas haloperoxidasas, metodo para oxidar un ion haluro, metodo para halogenar un compuesto y metodo para matar celulas microbianas o inhibir su
AR107020A2 (es) Vacuna de pcsk9 (proteína convertasa subtilisina-kexina tipo 9)
AR086511A2 (es) Agentes de union especifica al factor de crecimiento de hepatocitos
AR047347A1 (es) Miembros de la familia cry9 de bacillus
ES2542853T3 (es) Método para tratar miastenia grave
ES2155518T3 (es) Compuestos antimicrobianos de amplio espectro y metodo de uso.
AR066201A2 (es) Polinucleotidos optimizados para la expresion en plantas que codifican proteinas pesticidas, y metodo para controlar una plaga de plantas
PE20100253A1 (es) Mutantes de fgf21
ES2140082T3 (es) Composiciones peptidicas con actividad de tipo factor de crecimiento.
ATE332922T1 (de) Antimikrobiell wirkendes peptid
CO2021017664A2 (es) Péptidos
ATE103297T1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.
ES545760A0 (es) Procedimiento para preparar peptidos liberadores de la hormona del crecimiento.
CU24746B1 (es) Apirasas humanas, solubilizadas y modificadas útiles para prevenir y tratar el daño tisular
ES2180948T3 (es) Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal.
CO2024016693A2 (es) Péptido con actividad antimicrobiana
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
ES2199098T1 (es) Metodo para la extraccion y uso de peptidos que son activos como antibioticos para tratar enfermedades infecciosas.
ATA3552000A (de) Xylosyltransferase-gen
BRPI0720874C1 (pt) composições compreendendo peptídeos bioativos curtos para modulação celular e imunológica
DK1299541T3 (da) Fremgangsmåde til udvinding og anvendelse af nye humane defensiner som biologisk aktive proteiner til behandling af infektioner og andre sygdomme
ES2002915A6 (es) Un procedimiento para la preparacion de un peptido de veneno de serpiente que detiene el crecimiento.
AR045000A1 (es) Gen y proteina de eimeria , y su uso
AR005771A1 (es) Polipeptidos con actividad de mutanasa, secuencias de acidos nucleicos que los codifican, construccion de acidos nucleicos, vector de expresionrecombinante, celula huesped recombinante, metodos para producir los polipeptidos, polipeptido hibrido y uso de dichos polipeptidos para preparar